Patents by Inventor Jae Myun Lee

Jae Myun Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of diagnosing cancer and diagnosis kit using measurement of NK cell activity
    Patent number: 12379384
    Abstract: Provided are a method for diagnosing cancer, a diagnosis kit and compositions useful for measurement of NK cell activity. The incidence of cancer may be diagnosed by monitoring changes in the in vivo immune system through measurement of NK cell activity in blood. Thus, the incidence of cancer may be readily predicted as described herein using a blood sample from a subject.
    Type: Grant
    Filed: March 10, 2022
    Date of Patent: August 5, 2025
    Assignee: NKMAX CO., LTD.
    Inventors: Jae Myun Lee, Joo Chun Yoon, Sang Woo Park, Jong Sun Kim
  • ANTIVIRAL PHARMACEUTICAL COMPOSITION COMPRISING STEROID SULFATASE INHIBITOR
    Publication number: 20240082208
    Abstract: A steroid sulfatase inhibitor provided by the present invention is a safe substance without toxicity and adverse effects, has inhibitory activity against various viruses, and thus is capable of effectively preventing, ameliorating, or treating viral infections or diseases caused by viral infections.
    Type: Application
    Filed: January 10, 2022
    Publication date: March 14, 2024
    Inventors: Jung Taek Seo, Seok Jun Moon, Sung-Jin Kim, Jae Myun Lee, Pil-Gu Park, Su Jin Hwang, Moon Geon Lee
  • Method of diagnosing cancer and diagnosis kit using measurement of NK cell activity
    Patent number: 11442069
    Abstract: Provided are a method for diagnosing cancer, a diagnosis kit and compositions useful for measurement of NK cell activity. The incidence of cancer may be diagnosed by monitoring changes in the in vivo immune system through measurement of NK cell activity in blood. Thus, the incidence of cancer may be readily predicted as described herein using a blood sample from a subject.
    Type: Grant
    Filed: February 10, 2012
    Date of Patent: September 13, 2022
    Assignee: ATGEN CO. LTD.
    Inventors: Jae Myun Lee, Joo Chun Yoon, Sang Woo Park, Jong Sun Kim
  • METHOD OF DIAGNOSING CANCER AND DIAGNOSIS KIT USING MEASUREMENT OF NK CELL ACTIVITY
    Publication number: 20220229070
    Abstract: Provided are a method for diagnosing cancer, a diagnosis kit and compositions useful for measurement of NK cell activity. The incidence of cancer may be diagnosed by monitoring changes in the in vivo immune system through measurement of NK cell activity in blood. Thus, the incidence of cancer may be readily predicted as described herein using a blood sample from a subject.
    Type: Application
    Filed: March 10, 2022
    Publication date: July 21, 2022
    Applicant: ATGEN CO. LTD.
    Inventors: Jae Myun LEE, Joo Chun YOON, Sang Woo PARK, Jong Sun KIM
  • METHOD OF DIAGNOSING CANCER AND DIAGNOSIS KIT USING MEASUREMENT OF NK CELL ACTIVITY
    Publication number: 20140017713
    Abstract: Provided are a method for diagnosing cancer, a diagnosis kit and compositions useful for measurement of NK cell activity. The incidence of cancer may be diagnosed by monitoring changes in the in vivo immune system through measurement of NK cell activity in blood. Thus, the incidence of cancer may be readily predicted as described herein using a blood sample from a subject.
    Type: Application
    Filed: February 10, 2012
    Publication date: January 16, 2014
    Applicant: ATGEN CO. LTD.
    Inventors: Jae Myun Lee, Joo Chun Yoon, Sang Woo Park, Jong Sun Kim